ArticleCureus2026
Nitrous Oxide-Induced Myelopathy: A Case From French-Speaking Switzerland.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recreational nitrous oxide (N₂O) use has increased worldwide, driven by its accessibility, low cost, and perception as a harmless "party drug." Chronic or heavy use can cause neurological complications through functional vitamin B₁₂ deficiency. Despite its growing prevalence, such cases remain rarely documented in French-speaking Switzerland. Our patient is a 27-year-old man of Cape Verdean origin who presented with rapidly progressive paresthesia and gait ataxia following heavy N₂O inhalation. Neurological examination revealed profound sensory ataxia and loss of vibration sense in the lower limbs. Laboratory tests showed low serum vitamin B₁₂ with markedly elevated methylmalonic acid and homocysteine levels. Cervical MRI demonstrated a T2-weighted hyperintensity of the dorsal columns (C1-C5) with the characteristic "inverted V" sign, consistent with posterior column myelopathy. Nerve conduction studies were normal, excluding polyneuropathy. Treatment with hydroxocobalamin and methionine supplementation was initiated; folate was started concomitantly rather than after vitamin B₁₂ normalization. At the three-month follow-up, the patient had discontinued vitamin therapy and resumed N₂O use, with persistent sensory deficits and ataxic gait. This case illustrates a typical presentation of N₂O-induced dorsal myelopathy due to functional vitamin B₁₂ deficiency. It represents a rare and probably underreported occurrence in French-speaking Switzerland. Clinicians should maintain high suspicion for N₂O toxicity in young adults presenting with unexplained sensory ataxia. Early recognition, sustained abstinence, and appropriate vitamin B₁₂ replacement are crucial to prevent irreversible neurological damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.